Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Viventia Bio Inc.
1657
Viventia Bio Inc.
Health Care
Technology
Biotechnology
Medical
Pharmaceuticals
Viventia Bio is the leader in developing next generation oncology therapeutics utilizing our proprietary Targeted Protein Therapeutic technology (TPT).
Suggest edits
Follow us
Companies in the same industry
Hercules Pharmaceuticals, Inc.
Ark Biosciences
Ultragenyx Pharmaceutical
Prospective Research
Sensulin
Karuna Pharmaceuticals
GTx, Inc.
Syntimmune
MicuRx Pharmaceuticals, Inc.
Vico Therapeutics
Alexa global traffic share
Overview
Add info
Acquired by
2
21 Sep 2016
Eleven Biotherapeutics
Location
Canada
Headquarters
Explore Canada
Acquisition
Seeking Alpha
,
businesswire
Eleven Biotherapeutics acquires Viventia Bio in all-stock deal
